Management Team

MANAGEMENT TEAM

AventaMed’s co-founders are Olive O’Driscoll, CEO and John Vaughan, CTO. They invented the Solo TTD and incorporated the company in 2013. Together with their team, Board and Clinical Advisors they are wholly dedicated to the commercial success of the product and improving pediatric quality of care. AventaMed was crowned Seedcorn’s Overall Winner for the Best Early Stage Company in 2014 and Emerging Medtech Company of the Year, Irish Medical Device Association (IMDA) in 2015. Since then, AventaMed has raised two investment rounds, securing more than €3m in funding. The AventaMed team have successfully completed clinical studies, achieved CE Mark regulatory approval of the Solo TTD device in Europe. They are now focused on European commercialization and gaining FDA clearance for Solo TTD.

BOARD OF DIRECTORS

Jack Cashman Board Chairman and Bernard Lim, Non-Executive Director bring over 50 years of medical device commercialization experience to the AventaMed team. Both have built companies from grass roots through to revenue and successful exits.

Management Team

Keith Jansen, President and CEO

Keith has more than 30 years of medical device experience in global healthcare sales, marketing, and general management. Keith began his medical device career at Boston Scientific (13 years) where he held multiple leadership roles with progressive responsibilities. Keith has extensive start-up and general management experience gained from serving on the senior management team of Cortek (exit to AlphaTec Spine), President and CEO at InaVein, LLC (exit to LeMaitre Vascular) and President and CEO of Vascular Insights. Most recently, Keith was the Senior Vice President, International, for the American Heart Association. Keith holds a bachelor’s degree from Bucknell University, Lewisburg, PA as well as a graduate diploma in Entrepreneurial Management from Boston University.

John Vaughan, CTO and Co-Founder

John has over 15 years of experience in the medical device industry and has worked for numerous large medical device companies such as Stryker and Guidant. He is most experienced in medical device product development, strategic regulatory planning, regulatory approval, IP development and product realization. He has invented, designed and commercially launched numerous products worldwide. He is also an inventor on over 50 patents.

Board of Directors

Rick Geoffrion, Chairman and Non-Executive Director

Rick has more than 35 years of management experience in the healthcare industry with more than 30 years in the cardiovascular device space. Rick currently serves as the Founder, President and Chief Executive Officer of Cyrano Therapeutics, a private company that has developed a treatment to restore the sense of smell and flavor in those who have lost it. The Company is targeting the Otolaryngology market. He is also a member of the Executive Committee and the Board of Directors for MDIC, the Medical Device Innovation Consortium. Rick has been the founder or co-founder of six medical device and one pharma company.

Olive O’Driscoll, Director and Co-Founder

Olive is a biomedical engineer with 18 years’ experience in the medical device and pharmaceutical industry. She has worked in multi-national and start-up companies in business, clinical and regulatory roles in the areas of oncology, cardiovascular and orthopedics. Olive has led international clinical trials with more than 15,000 patients in 200 countries, with subsequent EU and USA clearances. Having invented and developed the Solo TTD, Olive established AventaMed with co-founder John Vaughan in 2013.

John Vaughan, CTO and Co-Founder

Jack Cashman, Non-Executive Director

Jack Cashman has held senior positions in International business and been a Board member for several companies in North America and Europe. He is now a Director of Telesat Holdings Inc. (Canada) and Mettrum Health Corp. (Canada). He was Chairman of Vectura Plc taking it public on the London Stock Exchange and Chairman and joint-CEO of RP Scherer, taking it public on The New York Stock Exchange.

Bruce Clibborn, Board Member

Bruce is a lead investor with Boole, Ireland’s most active angel investment syndicate where he has evaluated and led investments in medical devices and software companies since 2011. He began his career as an engineer designing HIPAA-compliant electronic data storage solutions for the US healthcare industry with pioneering cloud storage hardware manufacturer Raidtec. Bruce graduated with a BA in Electronic and Microelectronic Engineering from Trinity College Dublin and has an MBA in Finance from London Business School.

Bernard Lim, Non-Executive Director

Bernard Lim founded a medical devices company and led its growth and sale to a global pharmaceutical. In addition, he has led and grown companies spanning biotechnology, diagnostics, medtech, electronics and high technology across US, Canada and Europe in leadership roles as Chair, CEO and SVP. In addition to AventaMed, Bernard is Chair and CEO of Andersdx (UK), Chair of Altus Assessments (Canada) and Executive-in-Residence, Ontario Regional Innovation Centre (Canada).

Aidan O'Driscoll, Board Member

Aidan has spent the last twenty-five years in the technology sector with indigenous and multi-national companies. He has held senior positions in Finance, Operations, Sales and General Management. He has been involved in raising equity finance, setting up overseas operations, trade sales and a management buyout. He has spent the last number of years as an independent consultant working with companies in setting and implementing their strategic direction in the area of sales, marketing, finance and strategic management. Aidan is a founding member of Irrus Investments and a Fellow of the Institute of Chartered Accountants in Ireland.